QUOTED. 8 June 2021. Kelly Foote.
Executive Summary
Medtronic said it will launch the SenSight directional lead system used in deep brain stimulation following the approval by the US FDA. See what Kelly Foote, neurosurgeon at the University of Florida, said about the device here.
"The ability to continuously record brain activity while affected patients go about their daily lives is a powerful research tool that is rapidly improving our understanding of these brain circuitry disorders that diminish the lives of so many people." – Kelly Foote, neurosurgeon, University of Florida
- Find out more: Medtronic Announces FDA Approval Of SenSight Directional Lead System For Treating Movement Disorders
Click here for a free trial of Medtech Insight